{"transactions":[{"id":4617475,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-14T22:55:01.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":6140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on September 10, 2026. Price not applicable."}],"balance_after":6140,"source":{"system":"sec-edgar","filing":"0001628280-26-061940","document":"wk-form4_1789426499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1773367/000162828026061940/wk-form4_1789426499.xml","form_type":"4"}},{"id":311743,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Performance Shares","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":26939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board."}],"balance_after":26939,"derivative":{"expiration_date":"2029-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":26939},"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311742,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":17959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board."}],"balance_after":17959,"derivative":{"expiration_date":"2029-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":17959},"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311741,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Performance Shares","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":14052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each performance share unit converted into one share of common stock upon distribution in the first quarter of 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award."}],"balance_after":0,"derivative":{"expiration_date":"2026-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":14052},"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311740,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":2342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents vesting of one-quarter market share units granted on March 10, 2023."}],"balance_after":2342,"derivative":{"expiration_date":"2027-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":2342},"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311739,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":1107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents vesting of one-quarter market share units granted on March 10, 2022."}],"balance_after":0,"derivative":{"expiration_date":"2026-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":1107},"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311738,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3172,"price":60.13,"value":190732.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of awards."}],"balance_after":21528,"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311737,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"other","planned":false,"acquired":false,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board."}],"balance_after":24700,"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311736,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":14052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award."}],"balance_after":31600,"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311735,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":927,"price":60.13,"value":55740.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of awards."}],"balance_after":17548,"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311734,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"other","planned":false,"acquired":false,"shares":253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor."}],"balance_after":18475,"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311733,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":2342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents vesting of one-quarter market share units granted on March 10, 2023."}],"balance_after":18728,"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311732,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":436,"price":60.13,"value":26216.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of awards."}],"balance_after":16386,"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311731,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"other","planned":false,"acquired":false,"shares":124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor."}],"balance_after":16822,"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":311730,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2026-03-12T20:20:12.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents vesting of one-quarter market share units granted on March 10, 2022."}],"balance_after":16946,"source":{"system":"sec-edgar","filing":"0001773367-26-000002","document":"wk-form4_1773346808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000177336726000002/wk-form4_1773346808.xml","form_type":"4"}},{"id":324146,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Performance Shares","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":35146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board."}],"balance_after":35146,"derivative":{"expiration_date":"2028-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":35146},"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324145,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Performance Shares","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":6641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"Each performance share converted into one share of common stock upon distribution in the first quarter of 2025 in accordance with the terms of the award and certification of performance results by the Board."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award."}],"balance_after":0,"derivative":{"expiration_date":"2025-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":6641},"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324144,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":23431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board."}],"balance_after":23431,"derivative":{"expiration_date":"2028-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":23431},"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324143,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":2342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents vesting of one-quarter market share units granted on March 10, 2023."}],"balance_after":4684,"derivative":{"expiration_date":"2027-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":2342},"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324142,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":1107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents vesting of one-quarter market share units granted on March 10, 2022."}],"balance_after":1107,"derivative":{"expiration_date":"2026-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":1107},"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324141,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":1165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents vesting of one-quarter market share units granted on March 10, 2021."}],"balance_after":0,"derivative":{"expiration_date":"2025-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":1165},"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324140,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1860,"price":63.11,"value":117384.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of awards."}],"balance_after":15839,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324139,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"other","planned":false,"acquired":false,"shares":2449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board."}],"balance_after":17699,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324138,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":6641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award."}],"balance_after":20148,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324137,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":862,"price":63.11,"value":54400.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of awards."}],"balance_after":13507,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324136,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"other","planned":false,"acquired":false,"shares":399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor."}],"balance_after":14369,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324135,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":2342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents vesting of one-quarter market share units granted on March 10, 2023."}],"balance_after":14768,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324134,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":406,"price":63.11,"value":25622.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of awards."}],"balance_after":12426,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324133,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"other","planned":false,"acquired":false,"shares":193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor."}],"balance_after":12832,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324132,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents vesting of one-quarter market share units granted on March 10, 2022."}],"balance_after":13025,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324131,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":482,"price":63.11,"value":30419.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of awards."}],"balance_after":11918,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324130,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"other","planned":false,"acquired":false,"shares":80,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor."}],"balance_after":12400,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":324129,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-13T01:39:45.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents vesting of one-quarter market share units granted on March 10, 2021."}],"balance_after":12480,"source":{"system":"sec-edgar","filing":"0000014272-25-000072","document":"wk-form4_1741829979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000072/wk-form4_1741829979.xml","form_type":"4"}},{"id":337613,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Performance Shares","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":23220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F15","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2027."}],"balance_after":23220,"derivative":{"expiration_date":"2027-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":23220},"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337612,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Performance Shares","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":6985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F14","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return."}],"balance_after":0,"derivative":{"expiration_date":"2024-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":6985},"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337611,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":15480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":15480,"derivative":{"expiration_date":"2028-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":15480},"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337610,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"other","planned":false,"acquired":false,"shares":2342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%."},{"field":"shares","element":"transactionShares","label":"F13","text":"Represents the cancellation of one-quarter of market share units granted on March 10, 2023 due to the 80% minimum payout factor not being achieved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":7026,"derivative":{"expiration_date":"2027-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":2342},"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337609,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"other","planned":false,"acquired":false,"shares":1107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%."},{"field":"shares","element":"transactionShares","label":"F11","text":"Represents the cancellation of one-quarter of market share units granted on March 10, 2022 due to the 80% minimum payout factor not being achieved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":2214,"derivative":{"expiration_date":"2026-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":1107},"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337608,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":1164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents vesting of one-quarter of market share units granted on March 10, 2021."}],"balance_after":1165,"derivative":{"expiration_date":"2025-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":1164},"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337607,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Market Share Units","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents vesting of one-quarter of market share units granted on March 10, 2020."}],"balance_after":0,"derivative":{"expiration_date":"2024-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":994},"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337606,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1436,"price":53.79,"value":77242.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of awards."}],"balance_after":11315,"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337605,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"other","planned":false,"acquired":false,"shares":2431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board."}],"balance_after":12751,"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337604,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":6985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Amount represents distribution of performance shares earned under the 2021-2023 Long-Term Performance Award."}],"balance_after":15182,"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337603,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":283,"price":53.79,"value":15222.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of awards."}],"balance_after":8197,"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337602,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"other","planned":false,"acquired":false,"shares":201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor."}],"balance_after":8480,"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337601,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents vesting of one-quarter of market share units granted on March 10, 2021."}],"balance_after":8681,"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337600,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":246,"price":53.79,"value":13232.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of awards."}],"balance_after":7517,"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337599,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"other","planned":false,"acquired":false,"shares":157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor."}],"balance_after":7763,"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":337598,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2024-03-13T01:21:28.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents vesting of one-quarter of market share units granted on March 10, 2020."}],"balance_after":7920,"source":{"system":"sec-edgar","filing":"0000014272-24-000074","document":"wk-form4_1710292877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000074/wk-form4_1710292877.xml","form_type":"4"}},{"id":343900,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Restricted Stock Units","published_at":"2023-12-05T23:23:28.000Z","date":"2023-12-02","kind":"exercise","planned":false,"acquired":false,"shares":616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit vests in four equal annual installments beginning on December 2, 2020."}],"balance_after":0,"derivative":{"expiration_date":"2023-12-02","underlying":"Common Stock, $0.10 par value","underlying_shares":616},"source":{"system":"sec-edgar","filing":"0000014272-23-000195","document":"wk-form4_1701818599.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427223000195/wk-form4_1701818599.xml","form_type":"4"}},{"id":343899,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2023-12-05T23:23:28.000Z","date":"2023-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":274,"price":50.1,"value":13727.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of awards."}],"balance_after":6926,"source":{"system":"sec-edgar","filing":"0000014272-23-000195","document":"wk-form4_1701818599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427223000195/wk-form4_1701818599.xml","form_type":"4"}},{"id":343898,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2023-12-05T23:23:28.000Z","date":"2023-12-02","kind":"exercise","planned":false,"acquired":true,"shares":616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock unit vests in four equal annual installments beginning on December 2, 2020."}],"balance_after":7200,"source":{"system":"sec-edgar","filing":"0000014272-23-000195","document":"wk-form4_1701818599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427223000195/wk-form4_1701818599.xml","form_type":"4"}},{"id":346924,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Research Officer"}}],"security":"Common Stock, $0.10 par value","published_at":"2023-08-07T21:24:35.000Z","date":"2023-08-03","kind":"sale","planned":false,"acquired":false,"shares":732,"price":61.14,"value":44754.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.142 to $61.145, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":6584,"source":{"system":"sec-edgar","filing":"0000014272-23-000154","document":"wk-form4_1691443460.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427223000154/wk-form4_1691443460.xml","form_type":"4"}},{"id":2570835,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T19:28:19.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As of September 14, 2021, Issuer was acquired in a cash tender by an indirect subsidiary of Sanofi, a French societe anonyme at a purchase price of $38.00 per share (the \"Tender Offer\"), as described more fully in the Schedule 14D-9 filed by the Issuer on August 16, 2021.  Under the terms of the Tender Offer, Issuer outstanding stock options, if not vested became vested, and all Issuer stock options were converted into cash consideration at the amount of the difference between the exercise price of the option and the Tender Offer price of $38.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on June 16, 2021. This option will vest and become exercisable in full on the one year anniversary of the date of the award, or if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant."}],"balance_after":0,"derivative":{"exercise_price":20.43,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-056055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121056055/doc4.xml","form_type":"4"}},{"id":2570834,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T19:28:19.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As of September 14, 2021, Issuer was acquired in a cash tender by an indirect subsidiary of Sanofi, a French societe anonyme at a purchase price of $38.00 per share (the \"Tender Offer\"), as described more fully in the Schedule 14D-9 filed by the Issuer on August 16, 2021.  Under the terms of the Tender Offer, Issuer outstanding stock options, if not vested became vested, and all Issuer stock options were converted into cash consideration at the amount of the difference between the exercise price of the option and the Tender Offer price of $38.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on June 16, 2020.  The shares underlying this option became fully vested on the date of the Issuer's annual meeting of stockholders following the date of the grant, or June 16, 2021."}],"balance_after":0,"derivative":{"exercise_price":15.33,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001209191-21-056055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121056055/doc4.xml","form_type":"4"}},{"id":2570833,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T19:28:19.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As of September 14, 2021, Issuer was acquired in a cash tender by an indirect subsidiary of Sanofi, a French societe anonyme at a purchase price of $38.00 per share (the \"Tender Offer\"), as described more fully in the Schedule 14D-9 filed by the Issuer on August 16, 2021.  Under the terms of the Tender Offer, Issuer outstanding stock options, if not vested became vested, and all Issuer stock options were converted into cash consideration at the amount of the difference between the exercise price of the option and the Tender Offer price of $38.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 18, 2019. The shares underlying this option became fully vested on the date of the Issuer's annual meeting of stockholders following the date of the grant, or June 16, 2020."}],"balance_after":0,"derivative":{"exercise_price":10.2,"expiration_date":"2029-06-17","underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001209191-21-056055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121056055/doc4.xml","form_type":"4"}},{"id":2570832,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T19:28:19.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":37800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As of September 14, 2021, Issuer was acquired in a cash tender by an indirect subsidiary of Sanofi, a French societe anonyme at a purchase price of $38.00 per share (the \"Tender Offer\"), as described more fully in the Schedule 14D-9 filed by the Issuer on August 16, 2021.  Under the terms of the Tender Offer, Issuer outstanding stock options, if not vested became vested, and all Issuer stock options were converted into cash consideration at the amount of the difference between the exercise price of the option and the Tender Offer price of $38.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on April 10, 2019. The shares underlying this option are scheduled to vest and become exercisable in equal monthly installments, beginning on May 10, 2019 and ending on the three year anniversary of April 10, 2019."}],"balance_after":0,"derivative":{"exercise_price":12.36,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":37800},"source":{"system":"sec-edgar","filing":"0001209191-21-056055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121056055/doc4.xml","form_type":"4"}},{"id":2666382,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T17:16:30.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest and become exercisable in full on the one year anniversary of the date of the award, or if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant."}],"balance_after":20000,"derivative":{"exercise_price":20.43,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-040986","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121040986/doc4.xml","form_type":"4"}},{"id":3109170,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-16T20:09:26.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest and become exercisable in full on the one year anniversary of the date of the award, or if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant."}],"balance_after":18900,"derivative":{"exercise_price":15.33,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001209191-20-037131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919120037131/doc4.xml","form_type":"4"}},{"id":3484278,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-19T16:25:35.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest and become exercisable in full on the one year anniversary of the date of the award, or if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant."}],"balance_after":18900,"derivative":{"exercise_price":10.2,"expiration_date":"2029-06-17","underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001209191-19-038022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919119038022/doc4.xml","form_type":"4"}},{"id":3557518,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-11T08:41:30.000Z","date":"2019-04-10","kind":"grant","acquired":true,"shares":37800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option are scheduled to vest and become exercisable in equal monthly installments, beginning on May 10, 2019 and ending on the three year anniversary of April 10, 2019."}],"balance_after":37800,"derivative":{"exercise_price":12.36,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":37800},"source":{"system":"sec-edgar","filing":"0001209191-19-024329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919119024329/doc4.xml","form_type":"4"}}]}